NEW_CURA-LEAF_1170x120_OCT

Fasenra

AllianceRx Walgreens Prime and Walgreens gain access to more specialty drugs

AllianceRx Walgreens Prime and Walgreens gain access to more specialty drugs

ORLANDO, Fla. and DEERFIELD, Ill.—AllianceRx Walgreens Prime, the combined central specialty and home delivery pharmacy formed by Walgreens and pharmacy benefit manager Prime Therapeutics LLC (Prime), and Walgreens, announce the availability of several new limited distribution drugs for its specialty patients. The new drugs treat rare conditions such as Huntington’s disease, severe asthma and cystic

AstraZeneca cleared to market Fasenra biologic for asthma

AstraZeneca cleared to market Fasenra biologic for asthma

WILMINGTON, Del. — AstraZeneca plans to release Fasenra, its newly approved biologic drug for severe asthma, to U.S. pharmacies in the coming weeks. Fasenra (benralizumab), approved this week by the Food and Drug Administration, is indicated for the add-on maintenance treatment of patients ages 12 and older with severe asthma and an eosinophilic phenotype. AstraZeneca said